Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance Imaging
Data up to Jan 2025
Total Citations Per Year
Abstract
References (57)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
2005 • 7,244 citations
Cost-Effectiveness in Health and Medicine
1996 • 6,853 citations
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
2003 • 3,497 citations
The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi Jews
1997 • 2,255 citations
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 • 2,170 citations
Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening
2005 • 1,800 citations
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
2004 • 1,687 citations
Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors that Influence Them: An Analysis of 27,825 Patient Evaluations
2002 • 1,650 citations
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
1995 • 1,602 citations
Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2Mutations
2002 • 1,448 citations
Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer
2003 • 1,286 citations
Surveillance of <EMPH TYPE="ITAL">BRCA1</EMPH> and <EMPH TYPE="ITAL">BRCA2</EMPH> Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination
2004 • 1,170 citations
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2004 • 1,103 citations
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)
2005 • 1,020 citations
Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation
2001 • 945 citations
The Beaver Dam Health Outcomes study
1993 • 748 citations
Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
2004 • 611 citations
Breast MR Imaging Screening in 192 Women Proved or Suspected to Be Carriers of a Breast Cancer Susceptibility Gene: Preliminary Results
2000 • 549 citations
Clinicopathologic Features of <EMPH TYPE="ITAL">BRCA</EMPH>-Linked and Sporadic Ovarian Cancer
2000 • 537 citations
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
2000 • 536 citations
Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening
2006 • 500 citations
Improved survival in women with BRCA‐associated ovarian carcinoma
2003 • 430 citations
Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1
1996 • 427 citations
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging
2005 • 394 citations
Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13
1997 • 389 citations
Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations
2000 • 266 citations
Cost-Effectiveness of Extending Screening Mammography Guidelines To Include Women 40 to 49 Years of Age
1997 • 258 citations
Effect of Screening and Adjuvant Therapy on Mortality From Breast Cancer
2006 • 237 citations
First experiences in screening women at high risk for breast cancer with MR imaging
2000 • 220 citations
Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors
2002 • 204 citations
A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false‐negative mammography
2002 • 198 citations
High grade and non-high grade ductal carcinomain situon dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement
2003 • 157 citations
Effect of Prevention Strategies on Survival and Quality-Adjusted Survival of Women With BRCA1/2 Mutations: An Updated Decision Analysis
2002 • 152 citations
The development of interval breast malignancies in patients with BRCA mutations
2004 • 151 citations
Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer
2000 • 148 citations
Effect of Genetic Cancer Risk Assessment on Surgical Decisions at Breast Cancer Diagnosis
2003 • 147 citations
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk.
2002 • 143 citations
Appropriateness of breast‐conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2
2004 • 127 citations
Utilization of Screening and Preventive Surgery Among Unaffected Carriers of aBRCA1orBRCA2Gene Mutation
2004 • 113 citations
Cost Comparison of Mastectomy Versus Breast-Conserving Therapy for Early-Stage Breast Cancer
2001 • 112 citations
Decision Analysis of Prophylactic Surgery or Screening for BRCA1 Mutation Carriers: A More Prominent Role For Oophorectomy
2002 • 90 citations
Cost of Illness Associated with Metastatic Breast Cancer
2004 • 83 citations
A natural history model of stage progression applied to breast cancer
2006 • 69 citations
The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations.
1999 • 62 citations
Cost-Utility Analysis of Chemotherapy Using Paclitaxel, Docetaxel, or Vinorelbine for Patients With Anthracycline-Resistant Breast Cancer
1999 • 61 citations
Chapter 12: A Stochastic Simulation Model of U.S. Breast Cancer Mortality Trends From 1975 to 2000
2006 • 47 citations
Economic outcomes of breast cancer survivorship: CALGB study 79804
2005 • 43 citations
Trends in Recall, Biopsy, and Positive Biopsy Rates for Screening Mammography in an Academic Practice
2005 • 43 citations
The economic burden of gynecologic cancers in California, 1998
2003 • 39 citations
Initial Experience with Surgical Treatment Planning in the Newly Diagnosed Breast Cancer Patient at High Risk for BRCA-1 or BRCA-2 Mutation
2004 • 33 citations
Breast Cancer and Fatigue
1998 • 31 citations
Cost analysis of breast conservation surgery compared with modified radical mastectomy with and without reconstruction
2000 • 30 citations
Is adjuvant therapy for older patients with node (−) early breast cancer cost-effective?
2004 • 27 citations
Tamoxifen As Chemoprevention in BRCA1 and BRCA2 Mutation Carriers With Breast Cancer: A Pilot Survey of Physicians
2003 • 26 citations
Breast MRI Screening in Patients with Increased Familial and/or Genetic Risk for Breast Cancer: A Preliminary Experience
2003 • 18 citations
Ethical Issues in Contrast-Enhanced Magnetic Resonance Imaging Screening for Breast Cancer
2002 • 10 citations
Prophylactic surgery and other strategies for reducing the risk of familial ovarian cancer
2003 • 5 citations
Cited By (0)
No citing papers found in database